TOZ-CL05: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study with an Open-Label Phase to Determine the Efficacy and Safety of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients with Parkinson's Disease Experiencing End-o

  • Zadikoff, Cindy (PD/PI)

Project: Research project

Project Details

Effective start/end date8/12/158/12/18


  • inVentiv Health Clinical (TOZ-CL05 // TOZ-CL05)
  • Biotie Therapies, Inc. (TOZ-CL05 // TOZ-CL05)